MOACM
KPTI icon

Mutual of America Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History

Mutual of America Capital Management’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,568
Closed -$2.25M – 1659
2021
Q2 		$2.25M Buy
14,568
+6,018
+70% +$873K 0.02% 932
2021
Q1 		$1.35M Sell
8,550
-472
-5% -$99.5K 0.01% 1051
2020
Q4 		$2.1M Sell
9,022
-190
-2% -$44K 0.02% 884
2020
Q3 		$2.02M Sell
9,212
-1,576
-15% -$385K 0.03% 817
2020
Q2 		$3.06M Buy
10,788
+1,578
+17% +$467K 0.04% 597
2020
Q1 		$2.65M Sell
9,210
-5,605
-38% -$1.55M 0.04% 567
2019
Q4 		$4.26M Sell
14,815
-102
-0.7% -$22.1K 0.05% 523
2019
Q3 		$2.15M Sell
14,917
-83
-0.6% -$11.3K 0.03% 827
2019
Q2 		$1.35M Buy
15,000
+10
+0.1% +$803 0.02% 1026
2019
Q1 		$1.31M Buy
14,990
+5,969
+66% +$662K 0.02% 1020
2018
Q4 		$1.27M Hold
9,021
– – 0.02% 989
2018
Q3 		$2.3M Sell
9,021
-1,347
-13% -$372K 0.03% 836
2018
Q2 		$2.64M Hold
10,368
– – 0.04% 754
2018
Q1 		$2.09M Hold
10,368
– – 0.03% 833
2017
Q4 		$1.49M Buy
10,368
+71
+0.7% +$11.4K 0.02% 978
2017
Q3 		$1.7M Hold
10,297
– – 0.03% 906
2017
Q2 		$1.4M Sell
10,297
-357
-3% -$52.8K 0.02% 973
2017
Q1 		$2.05M Buy
10,654
+4,852
+84% +$779K 0.04% 786
2016
Q4 		$818K Sell
5,802
-29
-0.5% -$3.92K 0.02% 1070
2016
Q3 		$851K Hold
5,831
– – 0.02% 1059
2016
Q2 		$587K Hold
5,831
– – 0.01% 1097
2016
Q1 		$780K Sell
5,831
-40
-0.7% -$4.42K 0.02% 1064
2015
Q4 		$1.17M Buy
5,871
+2,209
+60% +$478K 0.03% 925
2015
Q3 		$578K Buy
3,662
+1,030
+39% +$275K 0.01% 1093
2015
Q2 		$1.07M Hold
2,632
– – 0.02% 984
2015
Q1 		$1.21M Sell
2,632
-76
-3% -$32.8K 0.03% 945
2014
Q4 		$1.52M Buy
2,708
+43
+2% +$24.4K 0.03% 829
2014
Q3 		$1.4M Hold
2,665
– – 0.03% 852
2014
Q2 		$1.86M Sell
2,665
-162
-6% -$75.4K 0.04% 727
2014
Q1 		$1.31M Buy
+2,827
New +$1.43M 0.03% 877

Other funds holding KPTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mutual of America Capital Management's KPTI Position: Q3 2021 in Review

Mutual of America Capital Management sold out of Karyopharm Therapeutics (KPTI) in Q3 2021, closing a stake of 14,568 shares — an estimated $2.25M sold.

Mutual of America Capital Management first reported a position in KPTI in Q1 2014 and held it in 30 quarters. The position peaked at $4.26M in Q4 2019. 134 funds tracked by Wall St. Rank hold KPTI as of Q3 2021.

  • Mutual of America Capital Management reported no remaining Karyopharm Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 14,568 Karyopharm Therapeutics shares in Q3 2021, an estimated $2.25M.
  • Mutual of America Capital Management first reported a position in Karyopharm Therapeutics in Q1 2014 and held it in 30 quarters.
  • Mutual of America Capital Management's Karyopharm Therapeutics position peaked at $4.26M in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.